Real-world clinical outcome of cefiderocol for treatment of multidrug-resistant non-fermenting, gram negative bacilli infections: a case seriesBaptiste Hoellinger, Yvon Ruch, Célestine Simand et al.|Clinical Microbiology and Infection|2022Cited by 25
Cefiderocol susceptibility of Achromobacter spp.: study of an accurately identified collection of 230 strainsVincent Jean-Pierre, Nathalie Wilhelm, Lucile Cadot et al.|Annals of Clinical Microbiology and Antimicrobials|2024Cited by 11
Mutations in genes <i>lpxL1</i> , <i>bamA</i> , and <i>pmrB</i> impair the susceptibility of cystic fibrosis strains of <i>Pseudomonas aeruginosa</i> to murepavadinAya Ghassani, Patricia Mariani, Pauline Triponney et al.|Antimicrobial Agents and Chemotherapy|2023Cited by 8
P229 Do CFTR modulators interfere with microbiological diagnosis?Geneviève Héry-Arnaud, Laurence Delhaès, Sophie Vallet et al.|Journal of Cystic Fibrosis|2024Cited by 0